TY - JOUR
T1 - Is there a role for probiotics in irritable bowel syndrome?
AU - Camilleri, Michael
PY - 2006/12/1
Y1 - 2006/12/1
N2 - This brief review appraises the current evidence of the efficacy of probiotics, including lactobacilli, bifidobacteria, and VSL#3, in the treatment of irritable bowel syndrome (IBS). The mechanisms potentially important will be evaluated, with specific reference to immune function, effects on motility and intraluminal milieu. These experimental and clinical observations suggest that probiotics may play a role in the management of IBS.
AB - This brief review appraises the current evidence of the efficacy of probiotics, including lactobacilli, bifidobacteria, and VSL#3, in the treatment of irritable bowel syndrome (IBS). The mechanisms potentially important will be evaluated, with specific reference to immune function, effects on motility and intraluminal milieu. These experimental and clinical observations suggest that probiotics may play a role in the management of IBS.
KW - Bifidobacteria
KW - Irritable bowel syndrome
KW - Lactobacilli
KW - Probiotics
KW - VSL#3
UR - http://www.scopus.com/inward/record.url?scp=33846452536&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846452536&partnerID=8YFLogxK
U2 - 10.1016/S1590-8658(07)60007-3
DO - 10.1016/S1590-8658(07)60007-3
M3 - Article
C2 - 17259088
AN - SCOPUS:33846452536
SN - 1590-8658
VL - 38
SP - S266-S269
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
IS - SUPPL. 2
ER -